Evidence map›Paper›PMID 35764867›Full record

ArticleCNS drugs2022

Correction to: Changes in Cataplexy Frequency in a Clinical Trial of Lower‑Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.

Yves Dauvilliers, Karel Šonka, Richard K Bogan, Markku Partinen, Rafael Del Rio Villegas, Nancy Foldvary-Schaefer, Roman Skowronski, Abby Chen, Jed Black, Franck Skobieranda and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in CNS drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Yves DauvilliersSleep and Wake Disorders Centre, Department of Neurology, Gui de Chauliac Hospital, 80 Avenue Augustin Fliche, 34295, Montpellier, France. y-dauvilliers@chu-montpellier.fr.ORCID http://orcid.org/0000-0003-0683-6506
Karel ŠonkaDepartment of Neurology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Richard K BoganUniversity of South Carolina School of Medicine, Columbia, SC, USA.
Markku PartinenHelsinki Sleep Clinic, Terveystalo Healthcare, Helsinki, Finland.
Rafael Del Rio VillegasNeurophysiology and Sleep Disorders Unit, Vithas Hospitals, Madrid, Spain.
Nancy Foldvary-SchaeferSleep Disorders Center, Cleveland Clinic, Cleveland, OH, USA.
Roman SkowronskiJazz Pharmaceuticals, Palo Alto, CA, USA.
Abby ChenJazz Pharmaceuticals, Palo Alto, CA, USA.
Jed BlackJazz Pharmaceuticals, Palo Alto, CA, USA.
Franck SkobierandaJazz Pharmaceuticals, Philadelphia, PA, USA.
Michael J ThorpyAlbert Einstein College of Medicine, Bronx, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35764867
PMCPMC9259537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.